These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25124939)
1. Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: a randomized, multicentre, placebo-controlled double-blind phase II trial. Pflugfelder A; Andonov E; Weide B; Dirschka T; Schempp C; Stockfleth E; Stratigos A; Krüger-Krasagakis S; Bauer J; Garbe C; Eigentler TK Br J Dermatol; 2015 Apr; 172(4):926-32. PubMed ID: 25124939 [TBL] [Abstract][Full Text] [Related]
2. Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study. Huyke C; Reuter J; Rödig M; Kersten A; Laszczyk M; Scheffler A; Nashan D; Schempp C J Dtsch Dermatol Ges; 2009 Feb; 7(2):128-33. PubMed ID: 18808378 [TBL] [Abstract][Full Text] [Related]
3. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results. Stockfleth E; Kerl H; Zwingers T; Willers C Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801 [TBL] [Abstract][Full Text] [Related]
4. OLEOGEL-S10 TO ACCELERATE HEALING OF DONOR SITES: MONOCENTRIC RESULTS OF PHASE III CLINICAL TRIAL. Lipový B; Fiamoli M; Mager R; Jelínková Z; Jarkovský J; Chaloupková Z; Holoubek J; Suchánek I; Brychta P Acta Chir Plast; 2018; 59(3-4):129-134. PubMed ID: 29651853 [TBL] [Abstract][Full Text] [Related]
5. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses. Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of Oleogel-S10: A triterpene preparation for the treatment of epidermolysis bullosa. Schwieger-Briel A; Ott H; Kiritsi D; Laszczyk-Lauer M; Bodemer C Dermatol Ther; 2019 Jul; 32(4):e12983. PubMed ID: 31168940 [TBL] [Abstract][Full Text] [Related]
7. Oleogel-S10 Phase 3 study "EASE" for epidermolysis bullosa: study design and rationale. Kern JS; Schwieger-Briel A; Löwe S; Sumeray M; Davis C; Martinez AE Trials; 2019 Jun; 20(1):350. PubMed ID: 31186047 [TBL] [Abstract][Full Text] [Related]
8. Betulin wound gel accelerated healing of superficial partial thickness burns: Results of a randomized, intra-individually controlled, phase III trial with 12-months follow-up. Frew Q; Rennekampff HO; Dziewulski P; Moiemen N; ; Zahn T; Hartmann B Burns; 2019 Jun; 45(4):876-890. PubMed ID: 30559054 [TBL] [Abstract][Full Text] [Related]
9. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies. Swanson N; Smith CC; Kaur M; Goldenberg G J Drugs Dermatol; 2013 Nov; 12(11):1278-82. PubMed ID: 24196337 [TBL] [Abstract][Full Text] [Related]
10. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies. Swanson N; Smith CC; Kaur M; Goldenberg G J Drugs Dermatol; 2014 Feb; 13(2):166-9. PubMed ID: 24509967 [TBL] [Abstract][Full Text] [Related]
11. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial. Gebauer K; Shumack S; Cowen PS Br J Dermatol; 2009 Oct; 161(4):897-903. PubMed ID: 19545297 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12-month study. Garbe C; Basset-Seguin N; Poulin Y; Larsson T; Østerdal ML; Venkata R; Lear JT Br J Dermatol; 2016 Mar; 174(3):505-13. PubMed ID: 26471889 [TBL] [Abstract][Full Text] [Related]
13. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis. Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study. Kern JS; Sprecher E; Fernandez MF; Schauer F; Bodemer C; Cunningham T; Löwe S; Davis C; Sumeray M; Bruckner AL; Murrell DF; Br J Dermatol; 2023 Jan; 188(1):12-21. PubMed ID: 36689495 [TBL] [Abstract][Full Text] [Related]
16. Ingenol mebutate gel for actinic keratosis. Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254 [TBL] [Abstract][Full Text] [Related]
17. Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report. Seckin D; Cerman AA; Yildiz A; Ergun T J Drugs Dermatol; 2009 May; 8(5):451-4. PubMed ID: 19537367 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: A Phase III randomized double-blind vehicle-controlled parallel trial. Yang CC; Wong TW; Lee CH; Hong CH; Chang CH; Lai FJ; Lin SH; Chi CC; Lin TK; Yen H; Wu CH; Sheu HM; Lan CE J Dermatol Sci; 2018 Jun; 90(3):295-302. PubMed ID: 29530340 [TBL] [Abstract][Full Text] [Related]
19. Improvement of Actinic Keratoses Using Topical DNA Repair Enzymes: A Randomized Placebo-Controlled Trial. Stoddard M; Herrmann J; Moy L; Moy R J Drugs Dermatol; 2017 Oct; 16(10):1030-1034. PubMed ID: 29036257 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results. Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]